ARTICLE | Company News
KineMed, Pfizer deal
June 16, 2014 7:00 AM UTC
The companies again extended a 2012 non-exclusive research deal to use KineMed's Dynamic Proteomics technology to evaluate drug candidates on metabolic pathways involved in diseases such as Type II di...